Veltis implements mandatory batch-level COA for all research peptides in Mexico
Veltis is now publishing batch-specific Certificates of Analysis for every research peptide sold in Mexico, providing HPLC purity and mass-spectrometry identity data for every lot.
Mexico-based research peptide supplier Veltis has instituted a mandatory policy requiring a published Certificate of Analysis (COA) for every lot currently in its catalog. The move addresses long-standing concerns regarding documentation gaps in the online research-use-only (RUO) peptide market, where lot-specific traceability is often absent.
Each COA provided by the company includes the specific lot number, HPLC purity levels measured by peak area, and identity confirmation via mass spectrometry. Veltis maintains that these documents are published prior to a batch being made available for purchase and are removed once the stock is depleted to ensure buyers only access data relevant to their specific product shipment.
A company spokesperson stated that providing batch-specific data is essential for researchers, as general purity figures often fail to represent the actual material supplied. The company has also released a supplier verification checklist to assist researchers in evaluating documentation quality from other sources.
All products sold by Veltis are designated strictly for research use. The company does not promote its compounds for human consumption and maintains that batch-level transparency is a foundational requirement for rigorous research standards.